HANSOH PHARMA: FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2023
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH BIOTHEUS
HANSOH PHARMA: NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS
HANSOH PHARMA: Letter to Non-Register Shareholders - NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS
HANSOH PHARMA: Letter to Register Shareholders - NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS
HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10398 CAPSULES"
HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10501 TABLETS"
HANSOH PHARMA: REDEMPTION OF CONVERTIBLE BONDS PURSUANT TO EXERCISE OF PUT OPTION BY BONDHOLDERS
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10509 TABLETS"
HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME
HANSOH PHARMA: INSIDE INFORMATION - LICENSE AGREEMENT WITH GSK
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - INCLUSION OF THREE INNOVATIVE DRUGS IN THE UPDATED NATIONAL REIMBURSEMENT DRUG LIST
HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF "HS-10511 TABLETS"
HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "TEDIZOLID PHOSPHATE FOR INJECTION"
No Data